راهنمای ایمونوهیستوشیمی و هیبریداسیون درجا در کارسینوم‌های انسانی ۲۰۰۶
Handbook of Immunohistochemistry and in situ Hybridization of Human Carcinomas 2006

1. Cover image

2. Title page

3. Table of Contents

4. Handbook of Immunohistochemistry and in situ Hybridization of Human Carcinomas

5. Front Matter

6. Copyright page

7. Dedication

8. Authors and Coauthors of Volume 4

9. Foreword

10. Preface

11. Selected Definitions

12. Classification Scheme of Human Cancers

13. Identification of Tumor-Specific Genes

14. The Post-Translational Phase of Gene Expression in Tumor Diagnosis

15. Role of Tumor Suppressor BARD1 in Apoptosis and Cancer

16. Angiogenesis, Metastasis, and Epigenetics in Cancer

17. Can Effector Cells Really “Effect” an Anti-Tumor Response as Cancer Therapy?

18. Circulating Cancer Cells

19. Circulating Cancer Cells: Flow Cytometry, Video Microscopy, and Confocal Laser Scanning Microscopy

20. Gastrointestinal Carcinoma: An Introduction

21. Role of Immunohistochemical Expression of p53 in Gastric Carcinoma

22. Role of Immunohistochemical Expression of p53 and Vascular Endothelial Growth Factor in Gastric Carcinoma

23. Role of Immunohistochemical Expression of p150 in Gastric Carcinoma: The Association with p53, Apoptosis, and Cell Proliferation

24. Role of Immunohistochemical Expression of Ki-67 in Adenocarcinoma of Large Intestine

25. Role of Immunohistochemical Expression of KIT/CD117 in Gastrointestinal Stromal Tumors

26. Role of Immunohistochemical Expression of BUB1 Protein in Gastric Cancer

27. Role of Immunohistochemical Expression of Epidermal Growth Factor in Gastric Tumors

28. Role of Immunohistochemical Expression of Beta-Catenin and Mucin in Stomach Cancer

29. Loss of Cyclin D2 Expression in Gastric Cancer

30. Role of Immunohistochemical Expression of E-Cadherin in Diffuse-Type Gastric Cancer

31. Role of Immunohistochemical Expression of Adenomatous Polyposis Coli and E-Cadherin in Gastric Carcinoma

32. Immunohistochemical Expression of Chromogranin A and Leu-7 in Gastrointestinal Carcinoids

33. Role of Immunohistochemical Expression of MUC5B in Gastric Carcinoma

34. Angiogenin in Gastric Cancer and Its Roles in Malignancy

35. Role of Helicobacter pylori in Gastric Cancer

36. Protein Alterations in Gastric Adenocarcinoma

37. Vesicle Proteins in Neuroendocrine and Nonendocrine Tumors of the Gastrointestinal Tract

38. Role of Immunohistochemical Expression of Caspase-3 in Gastric Carcinoma

39. Role of Immunohistochemical Expression of PRL-3 Phosphatase in Gastric Carcinoma

40. Role of Immunohistochemical Expression of DNA Methyltransferase 1 Protein in Gastric Carcinoma

41. Role of Immunohistochemical Expression of Cytoplasmic Trefoil Factor Family-2 in Gastric Cancer

42. Role of Immunohistochemical Expression of Cytokeratins in Small Intestinal Adenocarcinoma

43. Quantitative Immunohistochemistry by Determining the Norm of the Image Data File

44. Ovarian Carcinoma: An Introduction

45. Methods for Detecting Genetic Abnormalities in Ovarian Carcinoma Using Fluorescence in situ Hybridization and Immunohistochemistry

46. Role of Immunohistochemical Expression of HER2/neu in High-Grade Ovarian Serous Papillary Cancer

47. Role of Immunohistochemical Expression of BRCA1 in Ovarian Carcinoma

48. Role of BRCA1/BRCA2 in Ovarian, Fallopian Tube, and Peritoneal Papillary Serous Carcinoma

49. K-Ras Mutations in Serous Borderline Tumors of the Ovary

50. Role of Immunohistochemical Expression of Ki-67 in Ovarian Carcinoma

51. Role of Expression of Estrogen Receptor β, Proliferating Cell Nuclear Antigen, and p53 in Ovarian Granulosa Cell Tumors

52. Role of Immunohistochemical Expression of Cyclooxygenase-2 in Ovarian Serous Carcinoma

53. Role of Immunohistochemical Expression of Cyclooxygenase and Peroxisome Proliferator–Activated Receptor γ in Epithelial Ovarian Tumors

54. CDX2 Immunostaining in Primary and Secondary Ovarian Carcinomas

55. Epithelial Ovarian Cancer and the E-Cadherin–Catenin Complex

56. Role of Cytokeratin Immunohistochemistry in the Differential Diagnosis of Ovarian Tumors

57. Role of Immunohistochemical Expression of Cytokeratins and Mucins in Ampullary Carcinomas

58. Role of Integrins in Ovarian Cancer

59. Role of Immunohistochemical Expression of Vascular Endothelial Growth Factor C and Vascular Endothelial Growth Factor Receptor 2 in Ovarian Cancer

60. Use of Microarray in Immunohistochemical Localization of SMAD in Ovarian Carcinoma

61. Role of Immunohistochemical Expression of Fas in Ovarian Carcinoma

62. Role of Immunohistochemical Expression of Lewis Y Antigen in Ovarian Carcinoma

63. Role of Immunohistochemical Expression of ETS-1 Factor in Ovarian Carcinoma

64. Role of MCL-1 in Ovarian Carcinoma

65. Role of Elf-1 in Epithelial Ovarian Carcinoma: Immunohistochemistry

66. Role of Immunohistochemical Expression of OCT4 in Ovarian Dysgerminoma

67. Immunohistochemical Validation of B7-H4 (DD-O110) as a Biomarker of Ovarian Cancer: Correlation with CA-125

68. Role of Immunohistochemical Expression of Alpha Glutathione S-Transferase in Ovarian Carcinoma

69. Role of Immunohistochemical Expression of Aminopeptidases in Ovarian Carcinoma

70. Expression of Angiopoietin-1, Angiopoietin-2, and Tie2 in Normal Ovary with Corpus Luteum and in Ovarian Carcinoma

71. The Role of Immunohistochemical Expression of 1,25-Dihydroxyvitamin-D3-Receptors in Ovarian Carcinoma

72. Role of Immunohistochemical Expression of Antigens in Neuroendocrine Carcinoma of the Ovary and Its Differential Diagnostic Considerations

73. Role of Immunohistochemistry in Elucidating Lung Cancer Metastatic to the Ovary from Primary Ovarian Carcinoma

74. Index